Penas, F., Carta, D., Dmytrenko, G., Mirkin, G., Modenutti, C., Cevey, A., . . . Goren, N. Treatment with a new peroxisome proliferator-activated receptor gamma agonist, pyridinecarboxylic acid derivative, increases angiogenesis and reduces inflammatory mediators in the heart of Trypanosoma cruzi-infected mice.
Cita Chicago Style (17a ed.)Penas, F.N, et al. Treatment with a New Peroxisome Proliferator-activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-infected Mice.
Cita MLA (8a ed.)Penas, F.N, et al. Treatment with a New Peroxisome Proliferator-activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-infected Mice.